71 filings
Page 4 of 4
8-K
9ivontocv8tspxi
27 May 20
CNS Provides Update on Development
5:15pm
8-K
juikrqwxsc
18 May 20
CNS Announces Nasdaq Trading Halt Pending Receipt of Additional Information
5:23pm
8-K
zyj zd9gmlh3eo1
26 Mar 20
Entry into a Material Definitive Agreement
4:30pm
8-K
glkb53hraitzrstxmdm
12 Mar 20
CNS Pharmaceuticals Announces Business Highlights and 2019 Fourth Quarter Financial Results
4:29pm
8-K
manrvu1
10 Mar 20
Regulation FD Disclosure
4:05pm
8-K
pfn4adx5 qpr
2 Mar 20
Regulation FD Disclosure
2:15pm
8-K
4m8pccu26usc4 1m2lei
16 Jan 20
Entry into a Material Definitive Agreement
4:40pm
8-K
8xsjhf rmto
16 Jan 20
Regulation FD Disclosure
10:18am
8-K
x5b0ycinl 730wwktx
13 Jan 20
Regulation FD Disclosure
10:24am
8-K
nw7n1g1
22 Nov 19
CNS Pharmaceuticals Announces Full Exercise of Over-Allotment Option
8:00am
8-K
bvikbwm hn
14 Nov 19
CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock
12:00am